Matthew Lorence has extensive experience in the molecular diagnostic, genomics, and life science tools industries, from start-up to highly-matrixed organizations, with a track record of growing existing businesses, building new businesses, and developing strategies to enter new markets. He has extensive experience in genomic technologies, including NGS and Sanger sequencing, RT-PCR, and microarrays, with broad knowledge of the CLIA regulations related to the development of LDTs based on these technologies. Dr. Lorence also has extensive experience with the FDA through multiple interactions with different FDA centers. He is currently Principal at Halteres Associates, a bioscience consultancy specializing in Point-of-Care Diagnostics and Global Health. Prior to joining Halteres, he served as SVP, Global Marketing at CalibreScientific, CEO at Concise Separations and President and CEO of Edge Biosystems. He also served as Senior Vice-President of Marketing and Business Development for TessArae, and in several marketing and business development roles for at Affymetrix, Applied Biosystems, BioGenex and Bio-Rad Laboratories.

Dr. Lorence has authored 20 publications in peer-reviewed journals and given technical and commercial presentations at numerous international conferences and symposia. He earned his AB degrees in Genetics and Psychology from the University of California at Berkeley, and his PhD degree in Molecular Biology from the University of Texas at Dallas. As an NIH postdoctoral fellow in the Green Center for Reproductive Biology at the University of Texas Southwestern Medical Center at Dallas, Dr. Lorence earned his MBA degree with concentrations in Marketing and Business Strategy from the Jindal School of Management at the University of Texas at Dallas